Table 3.

Oral administration of FKA to mice induces QR activities in different tissues

	FKA mg/kg	QR (nmol DCP-IP reduced/min/mg protein)
	FKA mg/kg	0	3	7	15 (days of administration)
liver	0 (Control)	2648.06±183.35	2436.80±1398.10	2741.66±137.60	2765.72±2093.37
	100		4101.02±1105.19	3527.77±517.85^*	9634.45±5313.81^*
	200		8504.29±3470.56^*	4068.79±232.22^*	7068.51±3294.60^*
bladder	0	3449.71±209.77	3273.61±1415.96^*	3393.723±443.62	3681.79±100.181
	100		11737.22±4084.48^*	3467.52±688.35	5170.27±739.32^*
	200		10511.25±1472.25^*	3770.84±1072.36	3089.84±768.84
prostate	0	2802.91±64.67	2756.19±1587.58	2876.72±2198.77	2775.82±1878.86
	100		2310.67±226.59	5523.26±969.70^*	6807.09±1674.26^*
	200		2337.18±1150. 77	5119.12±4551.13	6411.29±1356.39^*
lung	0	4870.35±39.78	4851.78±527.02	4916.02±2880.84	4843.25±1181.73
	100		3857.17±1549.93	4524.02±5647.48	3473.61±1628.91
	200		4339.79±88.12	11079.75±1966.66^*	8950.10±2933.21
stomach	0	60479.048±3081.32	64021.47±5996.13	59000.77±14874.92	58416.41±12850.78
	100		57294.48±11656.99	50044.99±15353.51	91235.17±20875.47^*
	200		74057.26±30492.55	59889.06±9694.78	69008.18±11494.82
Small intestine	0	40637.76±1523.47	41885.29±4398.57	38927.15±2909.39	41100.84±18778.52
	100		74065.44±8922.01	43262.27±1309.49^*	54448.36±9452.83^*
	200		60568.51±2085.84	43810.33±472.22^*	47506.90±10479. 29

The data shown are means ± SD of five independent mice.

Statistically significant versus control group, P < 0.05 (t-test).